Tag:

Celldex Therapeutics

Latest Headlines

Latest Headlines

Avant, Celldex merge in $115M stock deal

FierceBiotech | October 22, 2007
Avant Immunotherapeutics is merging with Celldex Therapeutics in a stock deal valued at $115 million. Celldex shareholders will wind up with a majority of the shares in the merged company, which will
Related Tags

Celldex Therapeutics Press Releases

  • Celldex Therapeutics Announces Upcoming Presentation at Oppenheimer Healthcare Conference
  • Celldex Therapeutics Announces Upcoming Presentation at the Deutsche Bank 2012 dbAccess BioFEST
  • Celldex Therapeutics Announces Upcoming Presentation at Lazard Capital Markets Healthcare Conference
  • Celldex Announces Upcoming Data Presentation at the American Society of Hematology 54th Annual Meeting and Exposition
  • Celldex Reports Third Quarter 2012 Financial Results
Press Releases
  • anoDyne microneedle crowdfunds to finance human clinical trials
  • Sterigenics International to Triple West Memphis Sterilization Capacity with $15 Million Expansion
  • NovoCure Limited Announces Pricing of Initial Public Offering
  • Sarepta Therapeutics Announces Collaborative Research Agreement with Murdoch University Researchers Steve Wilton and Sue Fletcher
  • PlaqueTec announces the appointment of Dr Tim Brears as CEO
  • More Press Releases
Sponsored Links